BCM
ZYNE

BlueCrest Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

BlueCrest Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,194
Closed -$132K – 1504
2018
Q3 		$132K Sell
16,194
-65,396
-80% -$533K ﹤0.01% 1338
2018
Q2 		$795K Buy
+81,590
New +$795K 0.02% 584